Drug and vaccine authorizations for COVID-19: Overview

Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2020-11-04

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data